Library — CHDR

Search

Filter

Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation study.

Prins MLM, van der Plas JL, Vissers MFJM, Berends CL, Tresch G, Soergel M, Fernández E, van den Berge N, Duijsings D, Zitt C, Stavropoulou V, Zimmermann M, Drake RF, Burggraaf J, Groeneveld GH, Kamerling IMC

British journal of clinical pharmacology, 2022 Oct

View publication
Results of a randomized, placebo-controlled, first-in-human trial of topical CY-002 in patients with cutaneous warts.

Pagan L, Yfanti C, Rijneveld R, Todd M, Jongste P, Feijen JJ, Klaassen ES, Bouwes Bavinck JN, Struijk L, de Koning MNC, Prestegarden L, Niemeyer-van der Kolk T, van Poelgeest MIE, Rissmann R

Journal of the European Academy of Dermatology and Venereology : JEADV, 2022 Oct; 36(10):e773-e775

View publication
Teaching resources for the European Open Platform for Prescribing Education (EurOPE)-a nominal group technique study.

Bakkum MJ, Loobeek BJ, Richir MC, Papaioannidou P, Likic R, Sanz EJ, Christiaens T, Costa JN, Dima L, de Ponti F, Kramers C, van Smeden J, van Agtmael MA, Tichelaar J,

NPJ science of learning, 2022 Sep; 7(1):23

View publication
Students' guide to documentation in clinical trials.

Heck J, Rath AK, Wons K, Schumacher C, Kutschenko A, Noltemeyer N, Ulaganathan S, Voßiek LJ, Hijma H, van Smeden J, Schröder C, Stichtenoth DO, Wedemeyer H, Schindler C, Bosch JJ

European journal of clinical pharmacology, 2022 Sep

View publication
No effect of topical digoxin and furosemide for patients with actinic keratosis.

Huisman BW, Nené LEH, Linders FLL, Gambrah TK, van der Kolk TN, de Kam ML, Bavinck JNB, Burggraaf J, Feiss G, Rissmann R

Journal of the European Academy of Dermatology and Venereology : JEADV, 2022 Sep

View publication
Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds.

Radanovic I, Klarenbeek N, Rissmann R, Groeneveld GJ, van Brummelen EMJ, Moerland M, Bosch JJ

Frontiers in oncology, 2022 Sep

View publication
Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers.

Dijkstra F, O'Donnell P, Klaassen E, Buhl D, Asgharnejad M, Rosen L, Zuiker R, van Gerven J, Jacobs G

Translational psychiatry, 2022 Sep; 12(1):408

View publication
Driving Performance after Bedtime Administration of Daridorexant, Assessed in a Sensitive Simulator.

Muehlan C, Brooks S, Vaillant C, Meinel M, Jacobs GE, Zuiker RG, Dingemanse J

Clinical pharmacology and therapeutics, 2022 Sep; 111(6):1334-1342

View publication
Monitoring of Ex vivo Cyclosporin A Activity in Healthy Volunteers Using T Cell Function Assays in Relation to Whole Blood and Cellular Pharmacokinetics

Aliede E. in ’t Veld, Manon A. A. Jansen, Bertine W. Huisman, Mascha Schoonakker, Marieke L. de Kam, Dirk Jan A. R. Moes, Mariëtte I. E. van Poelgeest, Jacobus Burggraaf and Matthijss Moerland

Pharmaceutics, 2022 Sep

View publication

«
1
2
3
4
5
6
7
8
...
94
95
»